Research
Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk
Nature · By Marta Perez-Alcantara ·
The Brief
- Published online in Nature Genetics on 17 November 2026 (doi:10.1038/s41588-026-02843-0).
- Presents a scalable framework combining QTL mapping and CRISPR screening in pooled iPSC-derived microglia-like cells.
- Aims to link genetic determinants of gene expression and cellular phenotype to neurodegenerative risk.
Why it matters
It offers a method for connecting genetic variants to microglial gene expression and cell behaviour, which can help identify genetic drivers of neurodegenerative disease risk.
Who’s affected
- neuroscientists and geneticists studying neurodegenerative disease
- #microglia
- #crispr screening
- #qtl mapping
- #ipsc
- #neurodegeneration
- #genetics
Nature Genetics, Published online: 17 November 2026; doi:10.1038/s41588-026-02843-0 This study presents a scalable framework for understanding the genetic determinants of gene expression and cellular phenotype in stem-cell-derived microglia-like cells and linking these to…